Literature DB >> 7529103

The use of nebulized opioids for breathlessness: a chart review.

M Farncombe1, S Chater, A Gillin.   

Abstract

Breathlessness secondary to both cancer and non-malignant disease is a distressing, exhausting symptom which, to date, has been difficult to control. This paper reports a chart review undertaken on patients referred to the Ottawa Civic Hospital's Palliative Care Service over the 18-month period from 1 January 1992 to 30 June 1993. The intent of the review was to assess the recorded efficacy and safety of nebulized opioid use on patients with complaints of dyspnoea. Fifty-four patients were treated and subjective data have been compiled. The treatment was found to be effective, safe and convenient for the majority of the patients studied. In addition, nebulized opioids have been demonstrated as a treatment modality which is feasible for self-administration by the patient at home.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529103     DOI: 10.1177/026921639400800406

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  10 in total

1.  Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?

Authors:  B Eaton; J Hall; S MacDonald
Journal:  Can Fam Physician       Date:  1999-02       Impact factor: 3.275

Review 2.  Alternative opioids to morphine in palliative care: a review of current practice and evidence.

Authors:  M Barnett
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

3.  Nebulised drugs in palliative care.

Authors:  S Ahmedzai; C Davis
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 4.  [Terminal care medicine--basic principles and perspectives].

Authors:  B Knupp; W Stille
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 5.  Dyspnea: assessment and treatment.

Authors:  M Farncombe
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

6.  Effect of hydromorphone on ventilation in palliative care patients with dyspnea.

Authors:  Katri Elina Clemens; Eberhard Klaschik
Journal:  Support Care Cancer       Date:  2007-10-11       Impact factor: 3.603

7.  Effect of nebulized morphine on dyspnea of mustard gas-exposed patients: a double-blind randomized clinical trial study.

Authors:  Majid Shohrati; Mostafa Ghanei; Asghar Amini Harandi; Soniya Foroghi; Ali Amini Harandi
Journal:  Pulm Med       Date:  2012-03-19

8.  Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.

Authors:  Piotr Janowiak; Małgorzata Krajnik; Zygmunt Podolec; Tomasz Bandurski; Iwona Damps-Konstańska; Piotr Sobański; David C Currow; Ewa Jassem
Journal:  BMC Pulm Med       Date:  2017-12-11       Impact factor: 3.317

9.  Effect of low dose nebulized morphine on respiratory function improvement in mustard gas-exposed patients: A double-blind crossover clinical trial study.

Authors:  Samad Ghodrati; Mohammad Memarian; Shohreh Alian Samakkhah; Masoud Asadi-Khiavi; Aiyoub Pezeshgi
Journal:  Caspian J Intern Med       Date:  2022

Review 10.  Palliative management of refractory dyspnea in COPD.

Authors:  Hope E Uronis; David C Currow; Amy P Abernethy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.